The TPO mutation screening and genotype-phenotype analysis in 230 Chinese patients with congenital hypothyroidism.,Molecular and Cellular Endocrinology

当前位置： X-MOL 学术 › Mol. Cell. Endocrinol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

The TPO mutation screening and genotype-phenotype analysis in 230 Chinese patients with congenital hypothyroidism.
Molecular and Cellular Endocrinology ( IF 3.8 ) Pub Date : 2020-02-20 , DOI: 10.1016/j.mce.2020.110761
Rui-Jia Zhang ₁ , Feng Sun ₁ , Feng Chen ₂ , Ya Fang ₁ , Chen-Yan Yan ₁ , Chang-Run Zhang ₁ , Ying-Xia Ying ₁ , Zheng Wang ₁ , Cao-Xu Zhang ₁ , Feng-Yao Wu ₁ , Bing Han ₁ , Jun Liang ₃ , Shuang-Xia Zhao ₁ , Huai-Dong Song ₁

Affiliation

Inborn defects in thyroid hormone biosynthesis contribute to nearly half of congenital hypothyroidism (CH) cases in China. The thyroid peroxidase (TPO) mutation is one of the most frequent mutations that results in thyroid dyshormonogenesis. In this study, 35 non-synonymous mutations in 15 TPO sites, including 6 novel mutations, were identified in 230 Chinese patients with CH. The enzyme activity of the mutations in TPO was investigated in vitro, and patients with less than 15% residual enzyme activity showed severe CH, such as markedly increased thyroid-stimulating hormone (TSH) at diagnosis (>100 μIU/mL) and pronounced goiter, and required a higher dose of L-thyroxine to maintain the euthyroid. However, CH patients with greater than 16% TPO activity showed mild CH, a typical childhood socially without L-thyroxine treatment before 3 years of age, and the appearance of a macroscopic goiter at childhood. The findings indicated that the residual enzymatic activity of TPO was correlated with clinical phenotypes of CH patients with TPO biallelic mutations.

更新日期：2020-02-20

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南11